Tag Archive for ‘ACS Clinical Research Program’
The role of radiation therapy (RT) in the management of retroperitoneal sarcomas has been a longstanding topic of debate among physicians, and institutional and individual preferences have led to significant variability and inconsistencies in its use.1 The presumed benefit of RT in the management of retroperitoneal sarcomas has been inferred from its local control benefit […]
A summary of the ACS Clinical Research Program sessions at Clinical Congress 2019 is provided.
Recommendations from the second volume of Operative Standards for Cancer Surgery are highlighted.
The OPTI-Surg study evaluates an efficient screening and optimization tool for improving outcomes after major cancer surgery.
Appropriate surveillance and risk-reduction strategies for atypical ductal hyperplasia or lobular neoplasia are discussed.
An educational program developed jointly by the ACS CRP and the Society of Surgical Oncology provides surgeons with the tools they need to actively participate in clinical trials
Updates to the AJCC Cancer Staging Manual, including revisions to breast cancer staging content, are provided as is information on the manual’s second printing, including clarification of histologic codes.
Induction chemotherapy and minimally invasive transanal surgery to increase organ preservation in rectal cancer
The objectives of the NEO Trial (CCTG CO28) are described, specifically the feasibility and safety of induction chemotherapy and minimally invasive transanal surgery to allow sphincter preservation.
A summary of five ACS CRP Clinical Congress 2017 sessions is provided.
Gastric cancer is a significant cause of cancer morbidity and mortality in the U.S., with an estimated 26,370 new cases and 10,730 deaths in 2016.1 The incidence of gastric cancer is rising, particularly proximal tumors, and among young (< 40 years old) Caucasians, who have experienced a nearly 70 percent increase in the incidence of […]
The mission of the Dissemination and Implementation Committee—to provide surgeons with practice-changing results of the Alliance and other national clinical trial groups—is summarized.
Decision aids to enhance conversations with minority males entering prostate cancer treatment are described.
The Alliance for Clinical Trials in Oncology Foundation is accepting applications for the 2018 Alliance Scholar Awards.
Strategies for enhancing junior investigator participation in Alliance programs are highlighted.
The second volume of Operative Standards for Cancer Surgery, scheduled to be released in early 2017, describes operations for cancers of the esophagus, stomach, rectum, thyroid, and skin (melanoma).
Improving rectal cancer outcomes through advocacy, education, and research: The OSTRiCh Consortium and the new NAPRC
Over the last three decades, there has been a significant shift in cancer care from the generalist to the specialist setting. This shift is especially true in surgical oncology, where surgeons specializing in the care of breast cancer, esophageal cancer, and pancreatic cancer have become the norm for many facilities treating cancer patients in the […]
The approach, aims, and eligibility criteria of the NRG Oncology TNT clinical trial are summarized.
This month’s column underscores the importance of clinical trial participation, in particular surgeons who have a demonstrated capability and knowledge in conducting research-related operations.
Pancreatic cancer is the fourth-most common cause of cancer-related death in the U.S. and is predicted to soon be the third-leading cause. Surgical resection with pancreatectomy has historically been viewed as offering the only chance for cure. However, achieving negative margins at surgery can be difficult, with positive surgical margins found in as many as […]
This month’s column describes the role of diet and lifestyle on the development and outcomes of prostate cancer, and includes a brief overview of published and ongoing trials.